Search
for
Sort by
Research 271–300 of 1000+
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results
- 5PSQ-117 Effectiveness of baricitinib in alopecia areata
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- JAK inhibitor deuruxolitinib shows encouraging hair re-growth in alopecia areata
- Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study
- Bempikibart shows its potential for hair regrowth in alopecia areata
- Comparative study of efficacy of topical mometasone with calcipotriol versus mometasone alone in the treatment of alopecia areata
- Dermoscopic Analysis of Patients with and without Poor Prognostic Indicators in Alopecia Areata – A Comparative Study
- Management of Alopecia Areata through Unani Medicine
- BH20 An unintended sequela of hair regrowth: severe Janus kinase inhibitor-associated acneiform eruption in alopecia areata
- 54440 An open label trial evaluating the use of microneedling in hair loss
- BH15 The burden of alopecia areata: examining baseline health-related quality of life and clinical assessment tools
- Two‐dimensional planimetry for alopecia areata severity evaluation compared with severity of alopecia tool: A pilot study
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
- BH21 Efficacy and safety of oral Janus kinase inhibitors in the treatment of alopecia areata: a systematic review and meta-analysis
- BH31 Ritlecitinib for severe alopecia areata: does regional prescribing match national guidance?
- Outcomes of Down-Titration in Patients With Severe Scalp Alopecia Areata Treated With Baricitinib: An Update Through Week 152 From BRAVE-AA2
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- Serum level of vitamin D in patients with alopecia areata
- The in vitro Assembly of Hair Follicle Keratins: Comparison of Cortex and Companion Layer Keratins
- Comparison of efficacy, safety and satisfaction of latanoprost versus minoxidil, betamethasone and in combination in patients with alopecia areata: A blinded multiple group randomized controlled trial
- Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review
- Dietary Habits in Japanese Patients with Alopecia Areata
- Study on Serum Vitamin D in Alopecia Areata Patients